CalciMedica, Inc.
CALC
$2.30
$0.2813.61%
NASDAQ
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -10.16% | 66.35% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -28.50% | 27.96% | |||
| Operating Income | 28.50% | -27.96% | |||
| Income Before Tax | -253.78% | 146.25% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -253.78% | 146.25% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -253.78% | 146.25% | |||
| EBIT | 28.50% | -27.96% | |||
| EBITDA | 28.53% | -27.95% | |||
| EPS Basic | -242.29% | 146.30% | |||
| Normalized Basic EPS | -242.27% | 146.31% | |||
| EPS Diluted | -249.17% | 144.17% | |||
| Normalized Diluted EPS | -246.82% | 144.88% | |||
| Average Basic Shares Outstanding | 8.08% | -0.12% | |||
| Average Diluted Shares Outstanding | 4.73% | 3.08% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||